Disclaimer: This Blog,its owner,creator & contributor is neither a Research Analyst nor an Investment Advisor and expressing opinion only as an Investor in Indian equities. He/She is not responsible for any loss arising out of any information, post or opinion appearing on this blog.Investors are advised to do own due diligence and/or consult financial consultant before acting on any such information. Author of this blog not providing any paid service and not sending bulk mails/SMS to anyone.
Wednesday, June 23, 2010
ORCHID CHEMICALS AND PHARMACEUTICALS Ltd -BUY
Orchid Chemicals and Pharmaceuticals is a 1300 + Cr pharma company based in
Chennai promoted by Mr.K Raghavendra Rao
Orchid is the largest manufacturer of
Cephalosporin in India and one of the top
five in the world.Company has strong presence
in API and formulation segment.It is very strong
in R&D and has a special R&D wing in the name
of Orchid Research Laboratories with more than
130 scientists.Orchid's plants are approved by
various foreign agencies like US FDA and the
company is one of the largest exporter from India.
Last year was a disaster for orchid mainly
because of its huge debt burden and foreign
currency loss.Inorder to de-leverage ,company last
year sold its generic injectable finished dosage
business to 'HOSPIRA' and repaid loans worth
Rs.1400 Cr using part of this realisation .
Using part of the balance fund ,Orchid recently
aquired a company named Karalex Pharma .
This aquisition will be a boost for its marketing
efforts in US over next few years.company's bad times
are almost over and it is expected to post better
perfomance in the years to come.Orchid is expected
to post a turnover of Rs.1270 Cr and a net
profit of Rs.85 + Crore in current financial year .
Company recently declared a dividend
of Rs.10/- each (100%) too. Moreover after the reduction in debt
Orchid is a perfect takeover target due to its large size ,
quality of operations ,well established R&D and comparatively
low promoter stake At current market price of Rs.161 /- ,
Orchid is a decent BUY.
Labels:
cephalosporin
,
orchid chemicals
,
pharma industry
Subscribe to:
Post Comments
(
Atom
)
Dear Value-Pick,
ReplyDeleteSimilarly , Surya Pharma seems to be having a high EPS but also high debt. Its quoting at less than 4 PE. Is it worth the bet?
Your analysis would be highly appreciated.
Regards
K.Murali
Sorry I am little sceptical about Surys Pharma on various grounds.
ReplyDeleteHi Valuepick, Thanks for your gr8 recommendations, just want to bring in your notice that Kopran, has started its move , could you remind on your blog so that investor and take position in it. Just want to make your followe earn more, no other intention behind it.
ReplyDeleteUY SHIRPUR GOLD BSE CODE 512289@200/= FOR A TARGET OF 1500.GUYS GRAB IT.IT IS ZEE GROUP COMAPNY.PRODUCTION STARTING SOON.
ReplyDeleteBUY SHIRPUR GOLD BSE CODE 512289@200/= FOR A TARGET OF 1500.GUYS GRAB IT.IT IS ZEE GROUP COMAPNY.PRODUCTION STARTING SOON.
ReplyDeleteSHIRPUR GOLD 512289 CODE
ReplyDeleteFOR LATEST UPDATE:
KIRTISCRIPSCAN.NET
Words nahi hai Thareef karne ke liye, hamara great guru sharma ji, kya bole ga Sacchi Niklega. great. great. great..
he told only one thing. 100 shares of shirpur in comming years is equivalent to one Mercedes Benz.
It is true. Shirpur is going to Rock.. Hold it. dont sell it. Its goldmine....
opran bse code 524280@42/= is a great turnaround story of 2010.Exactly the same happend with LUPIN when it was quoting at 62/= way back in 2002 and looking at the low price I bought the stock in huge quantity.Lupin is now trades at 1900+ ex 1:1 bonus.I feel same thing is happening here with KOPRAN and looks super multibagger from hereon.In fact,it is another LUPIN in making.Good opportunity to grab such stocks and held on for super duper profits.Cheers.
ReplyDeletethanks.
ReplyDeleteAny visibility on current total debt and interest outgo?
with bulk of cashflow generating part sold off - what is the visibility for future cashflow for next 2 years?